期刊文献+

芋螺多肽Eb1.6的制备工艺研究 被引量:1

Preparation method of conopeptide Eb1.6
原文传递
导出
摘要 目的研究α-芋螺多肽Eb1.6的制备工艺,为其临床前实验奠定基础。方法采用Fmoc保护氨基酸,以Rink树脂为固相载体,N,N-二异丙基碳二酰亚胺(DIC)/1-羟基苯并三唑(HOBt)为缩合剂,手工固相法规模合成目标肽。线性肽折叠采用空气氧化法,将线性肽按0.2 mg/ml的浓度溶于0.1 mol/L NH4HCO3缓冲液中,室温下搅拌16~24 h。折叠结束后,加入Amberlite XAD16大孔吸附树脂富集,树脂用乙醇浸洗,旋转蒸发浓缩得折叠后粗品,然后进行反相纯化。结果 Eb1.6线性肽的粗产率为94.6%,Eb1.6折叠肽粗品的回收率为82.3%,粗品经C18反相纯化后纯度高于98.5%。结论以DIC/HOBt为缩合剂合成Eb1.6的纯度及产率均较高,Eb1.6折叠后用吸附树脂富集,乙醇浸泡再释放多肽,可实现缓冲体系及树脂的反复循环,降低了成本。 Objective To probe a method for large-scale synthesis of α-conopeptide Eb1.6 in order to provide a large quantity of α-conopeptide Eb1.6 for preclinical trial.Methods Starting with Rink resins and Fmoc-protected amino acids,linear Eb1.6 was synthesized by solid-phase peptide synthesis method(SPPS) in which DIC/HOBt was used as a coupling agent.The linear peptide(0.2 mg/ml) was folded in 0.1 mol/L NH4HCO3 buffer at room temperature for 16 to 24 h.The folded peptide was then absorbed by the Amberlite XAD16 resin,and desorbed by alcohol.Finally,the crude Eb1.6 was concentrated by rotary evaporation and purified by reversed-phase HPLC.Results The crude yield of linear peptide was 94.6%,and the recovery rate of folded Eb1.6 by Amberlite XAD16 was 82.3%.Eb1.6 with a purity of more than 98.5% was obtained after the purification of RP-HPLC.Conclusion The purity and yield of Eb1.6 are high when DIC/HOBt is used as a coupling agent.The absorption of Eb1.6 with Amberlite XAD16 resin and desorption by alcohol are a highly efficient method for concentration of folded Eb1.6 at a low cost.
出处 《军事医学》 CAS CSCD 北大核心 2013年第4期274-278,共5页 Military Medical Sciences
基金 海洋863项目(2011AA09070108) 国家973计划资助项目(2010CB529802)
关键词 α-芋螺多肽 Eb1 6 固相合成 折叠 纯化 α-conopeptide Eb1.6 solid-phase peptide synthesis method folding purification
  • 相关文献

参考文献15

  • 1McIntosh JM,Jones RM. Cone venom-from accidential stings todeliberate injection[ J]. Toxicon,2001,39( 10) : 1447 - 1451.
  • 2魏娟娟,戴秋云.α-芋螺毒素构效关系的研究进展[J].军事医学科学院院刊,2006,30(4):389-393. 被引量:11
  • 3Muttenthaler M, Akondi KB, Alewood PF. Structure-activity studies on alpha-conotoxins [ J ]. Curr Phann Des, 2011, 17 (38) : 4226 -4241.
  • 4Lewis RJ, Dutertre S,Vetter I,et al. Conus venom peptidepharmacology[ J]. Pharmacol Rev, 2012, 64(2) : 259 -298.
  • 5赵雪娇,姜山,何娟,孙美娜,李晖.α-芋螺毒素特异性结合受体-神经型烟碱乙酰胆碱受体的同源模建及功能预测[J].中国生化药物杂志,2012,33(3):213-216. 被引量:5
  • 6Kass Q,Westerman JC,Craik DJ. Conopeptide characterizationand classification : an analysis using ConoServer [ J ]. Toxicon,2010,55(8) : 1491 -1509.
  • 7Satkunanathan N , Livett B,Gayler K, et al. Alpha-conotoxinVcl. 1 alleviates neuropathic pain and accelerates functionalrecovery of injured neurons [ J]. Brain Res,2005,1059 ( 2 ):149 -158.
  • 8Napier IA, Klimis H, Rycroft BK, et al. Intrathecal a-conotox-ins Vcl. 1,AuIB and Mil acting on distinct nicotinic receptorsubtypes reverse signs of neuropathic pain[ J]. Neuropharmacolo-gy, 2012,62(7) : 2202 -2207.
  • 9Callaghan B,Haythomthwaite A, Berecki G, et al. Analgesic al-pha-conotoxins Vcl. 1 and Rgl A inhibit N-type calcium channelsin rat sensory neurons via GABAB receptor activation [ J ]. J Neu-rosci,2008,28(43) :10943 -10951.
  • 10Luo S, Akondi KB, Zhangsun D, et al. Atypical alpha-conotoxinLtIA from Conus litteratus targets a novel microsite of thealpha3beta2 nicotinic receptor [ J ]. J Biol Chem, 2010,285(16) : 12355 -12366.

二级参考文献53

  • 1Hillyard DR, Monje VD, Mintz IM, et al. A new conus peptide ligand for mammalian presynaptic Ca2+ channels[J]. Neuron,1992,9:69
  • 2Ramilo CA, Zafaralla GC, Nadasdi L, et al. Novtl c-and ωconotoxins from Conus striatus venom[J]. Biochemisstry, 1992,31:9919
  • 3Sato K, Raymond C, Martin-Moutot N, et al. Binding ofchimeric analogs of -conotoxin M VIIA and M VIIC the N-andP/Q-type calcium channels[J]. FEBS Letters, 1997,414:480
  • 4Monje VD, Haack JA, Naisbitt H, et al. A new conus peptide ligand for Ca channel subtypes[J]. Neuropharmacology, 1993,32(11): 1141
  • 5Rivier J, Galyean R, Gray WR, et al. Neuronal calcium channel inhibitors[J]. J Biol Chem, 1987, 262(3): 1194
  • 6Lozanov V, Guarnaccia C, Patthy A, et al. Synthesis and cys tine/cysteine-catalyzed oxidative folding of amaranth a-amylase inhibitor[J]. J Peptide Res, 1997, 50:65
  • 7Kubo S, Chino N, Kimura T, Sakakibara S. Oxidative folding of -conotoxin MVIIC: effects of temperature and salt[J]. Biopoly mer, 1996,38:733
  • 8Annis I, Chen L and Barany G. Novel solid-phase reagents for facile formation of intramoleculer disulfide bridges in peptides under mild condition[J]. J Am Chem Soc, 1998,120:7226
  • 9Gray WR. Disulfide structures of highly bridged pephde: A new strategy for analysis[J]. Protein Science, 1993,2:1732
  • 10Gray WR. Echistatin disulfide bridges: selective reduction and linkage[J]. Protein Science, 1993, 2:1749

共引文献19

同被引文献9

  • 1Lee MS.Recent progress in the discovery and development of N-type calcium channel modulators for the treatment of pain[J].Prog Med Chem,2014,53:147.
  • 2Pope JE,Deer TR.Ziconotide: a clinical update and pharmacologic review[J].Expert Opin Pharmacol Ther,2013,14(7):957.
  • 3Brady RM,Baell JB,Norton RS.Strategies for the development of conotoxins as new therapeutic leads[J].Mar Drugs,2013,11(7):2293.
  • 4Adams DJ,Berecki G.Mechanisms of conotoxin inhibition of N-type(Ca(v)2.2)calcium channels[J].Biochim Biophys Acta,2013,1828(7):1619.
  • 5Adams DJ,Callaghan B,Berecki G.Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type(CaV2.2)calcium channels[J].Br J Pharmacol,2012,166(2):486.
  • 6LIU Zhu-guo(刘珠果),DAI Qiu-yun(戴秋云),SUN Ting(孙婷),et al.Applications of a-conotoxins(α型芋螺多肽及其应用): China(中国),201010121879.7[P].2011-05-25.
  • 7ChP 2010.Vol Ⅱ(中国药典2010年版.二部)[S].2010:Appendix(附录)VD.
  • 8郭会芹,王于,付超,姬泓巍,戴秋云.新型抗凝血多肽Hirulog-S的质量分析[J].药物分析杂志,2011,31(10):1930-1933. 被引量:3
  • 9余硕,郭会芹,付超,徐艳,戴秋云.抗HIV融合多肽CP32M的质量分析[J].军事医学,2012,36(11):839-842. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部